There are currently 3 ongoing clinical trials involving Trichotillomania
Of the 3 trials,2 trials are in Phase II
Furthermore, 1 trials are in Phase II/III
The global pharmaceutical industry is steadily developing new drugs for Trichotillomania, a Central Nervous System condition. The largest number of ongoing clinical trials for Trichotillomania are conducted in the North America and Middle East and Africa.
University of Chicago and Ferdowsi University of Mashhad: The leading ongoing Trichotillomania related clinical trial sponsors
University of Chicago and Ferdowsi University of Mashhad are the top sponsors for Trichotillomania-related ongoing clinical trials.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward